Working… Menu

Comparison of Stapler Line Bleeding Control Techniquessurgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03240367
Recruitment Status : Completed
First Posted : August 7, 2017
Last Update Posted : August 7, 2017
Information provided by (Responsible Party):
Ersin Gündoğan, Inonu University

Brief Summary:
Introduction RYGB surgeon; Have become increasingly morbid obesity treatment methods with improvements in minimally invasive surgery. Ensuring patient comfort and early return to life are the criteria that should be given priority in this treatment method.The purpose of this study; Emphasizing that the cautery technique of the stapler line bleeding control methods is as successful as the other methods.

Condition or disease Intervention/treatment Phase
Obesity, Morbid Other: Coutery Not Applicable

Detailed Description:
The question of the availability of cautery in RYGB surgeons

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparison of Stapler Line Bleeding Control Techniques in Laparoscopic Gastric Bypass
Actual Study Start Date : December 4, 2016
Actual Primary Completion Date : July 14, 2017
Actual Study Completion Date : July 14, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding

Arm Intervention/treatment
Experimental: coutery
Stapler bloom will be stopped with cautery
Other: Coutery
Stapler line bleeding control with coutery

No Intervention: clips
Stapler bloom will be stopped with clipping

Primary Outcome Measures :
  1. 3-item drainage control [ Time Frame: 8 months ]
    Bleeding quantities to be noted

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Morbid obese patients

Exclusion Criteria:

  • Cirrhotic patients, those under 18 years of age, additional intraabdominal surgeries during LRYGBP and those who had previously undergone obesity surgery (revision surgery)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03240367

Layout table for location information
Inonu University
Malatya, Turkey, 44915
Sponsors and Collaborators
Ersin Gündoğan
Layout table for investigator information
Study Director: Ersin Gündoğan, MD study principal investigator

Layout table for additonal information
Responsible Party: Ersin Gündoğan, operator doctor, Inonu University Identifier: NCT03240367     History of Changes
Other Study ID Numbers: 2016/180
First Posted: August 7, 2017    Key Record Dates
Last Update Posted: August 7, 2017
Last Verified: July 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity, Morbid
Nutrition Disorders
Body Weight
Signs and Symptoms